Skip to main content

Life Science

NORTH AMERICAN REPORTS: July 2026

Hikma Pharmaceuticals invests $267 million in Ohio; Oklahoma revamps a former fuel refi nery; USA Rare Earth announces South Carolina as next mining production location; Japanese solar goes big in Texas; Rhode Island expands radar production; exports increase from Alabama’s Port of Mobile.

TENNESSEE VALLEY AUTHORITY: Prescription for Growth

When Eli Lilly and Company in December 2025 announced plans to invest more than $6 billion in a new active pharmaceutical ingredient (API) manufacturing facility in Huntsville, Alabama, the project immediately rewrote the state’s record books, becoming the largest private capital investment in Alabama’s history.

Report Examines Regional Impact of NIH

A coalition of top research institutions, patient and health advocates, and companies earlier this year published its annual analysis of jobs and economic activity supported by National Institutes of Health (NIH) research funding distributed to all 50 U.S. states and the District of Columbia.

BIOPHARMACEUTICALS: Will AI Help Save Lives?

Could AI save lives? Deployments by Moderna and Amgen will offer evidence. Arnold & Porter’s Global Life Sciences lead shares insights on the convergence of AI and life sciences.

California: SWISS DRUG MAKER BANKS ON THE GOLDEN STATE

How Vacaville became a biotech boomtown in the Bay Area. Plus updates on wildfire recovery, legislation, film production in San Diego, energy storage at Camp Pendleton and the state’s leadership in green building.